Business
Biotech M&A Boom Continues
Vertex Pharmaceuticals acquired Crinetics Pharmaceuticals for $10 billion, signaling a significant deal in the biotech industry. The acquisition aims to expand Vertex's portfolio with Crinetics' drug for a rare endocrine disorder.
Coverage timeline — 2 articles
STAT News
Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder, the companies announced.
2026-07-06 20:52 UTC
BBC Sport
Arthur Fery comes from a set down to beat Grigor Dimitrov after a fifth set tiebreak, becoming the first British wildcard to reach a Grand Slam quarter-final at Wimbledon 2026.
2026-07-06 21:04 UTC